Physician profile
Bidhan Das
NPI 1881832145
$349,659.15
in general payments reported to CMS, 2019-2025
41 companies · $78K in 2025
The $78K reported for 2025 was more than what 99% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94K · 2020: $42K · 2021: $21K · 2022: $39K · 2023: $16K · 2024: $60K · 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $99K · Consulting Fee: $22K · Travel and Lodging: $19K · Food and Beverage: $6,240 · Honoraria: $6,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $99,479.08 |
| Consulting Fee | $22,351.26 |
| Travel and Lodging | $19,357.58 |
| Food and Beverage | $6,239.54 |
| Honoraria | $6,120.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $88,953.69 | 2019-2022 | |
| Mimedx Group, INC. | $82,729.85 | 2024-2025 | Bovine Collagen |
| Vertex Pharmaceuticals Incorporated | $37,999.16 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $36,624.52 | 2019-2025 | Exparel, Iovera |
| Medtronic, INC. | $18,502.38 | 2021-2025 | Interstim, Signia |
| Convatec INC. | $17,726.89 | 2019-2025 | |
| Medtronic USA, INC. | $16,002.76 | 2019-2020 | |
| Biom'Up France Sas | $13,124.62 | 2020-2021 | |
| Biom'Up Sa | $10,185.47 | 2019 | |
| Suture Ease, INC. | $10,074.00 | 2019-2021 | |
| Ethicon US, LLC | $6,968.30 | 2019-2024 | Evarrest, Enseal, Echelon; Endopath |
| Ethicon Endo-Surgery INC. | $4,742.92 | 2024 | Enseal, Harmonic |
| Medical Device Business Services, INC. | $1,824.51 | 2024 | Echelon Flex |
| Gi Supply, INC. | $507.28 | 2019 | |
| Romark Laboratories, Lc | $454.21 | 2019-2020 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $399.81 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Covidien Lp | $325.00 | 2020 | |
| Shire North American Group INC | $265.19 | 2019 | |
| Intuitive Surgical, INC. | $250.63 | 2020-2025 | |
| Baxter Healthcare | $224.19 | 2020-2021 | |
| Axonics, INC. | $179.61 | 2021-2023 | Bulkamid, Axonics |
| Smith+Nephew, INC. | $165.80 | 2022-2023 | Stravix Pl |
| Thd America, INC. | $161.51 | 2024 | |
| Activ Surgical, INC. | $144.25 | 2024 | Activsight |
| Acera Surgical, INC. | $142.45 | 2025 | Restrata Wound Matrix |
| Davol INC. | $139.66 | 2023 | Arista Ah Flexitip |
| Baudax Bio INC. | $129.08 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $116.92 | 2020-2023 | Gattex |
| Heron Therapeutics, INC. | $110.71 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.41 | 2019-2021 | |
| Stryker Corporation | $105.99 | 2019 | |
| Braintree Laboratories, INC. | $44.33 | 2019-2023 | Sutab |
| Ferring Pharmaceuticals INC. | $40.67 | 2019 | |
| Abbvie INC. | $35.06 | 2024 | |
| Boston Scientific Corporation | $28.15 | 2025 | Resolution 360 Clip |
| Integra Lifesciences Corporation | $27.51 | 2023 | Codman Hakim, Cusa Clarity, Codman Certas |
| Wound Management Technologies, INC | $23.76 | 2019 | |
| Trevena, INC. | $22.86 | 2021 | |
| Olympus America INC. | $19.18 | 2019 | |
| Coopersurgical, INC. | $16.88 | 2020 | |
| Kerecis Limited | $11.98 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bidhan Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.